Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Venture Capital
Biotech
Frazier Life Sciences gathers $630M for small, mid-cap biotechs
Frazier Life Sciences has sourced a further $630 million for its fund focused on small and mid-cap biotechs.
James Waldron
Oct 2, 2024 9:30am
Fierce Biotech Fundraising Tracker: Triveni, Kailera & more
Oct 2, 2024 8:00am
I&I biotech Triveni raises $115M for preclinical antibodies
Oct 2, 2024 7:00am
Kailera launches with $400M series A, 4 Chinese obesity drugs
Oct 1, 2024 8:30am
Big Pharma backers return for Aktis' $175M series B
Sep 30, 2024 8:00am
Arch closes $3B-plus fund to foster biopharma upstarts
Sep 26, 2024 10:24am
